ERINACINE E AS A KAPPA-OPIOID RECEPTOR AGONIST AND ITS NEW ANALOGS FROM A BASIDIOMYCETE, HERICIUM-RAMOSUM

Citation
T. Saito et al., ERINACINE E AS A KAPPA-OPIOID RECEPTOR AGONIST AND ITS NEW ANALOGS FROM A BASIDIOMYCETE, HERICIUM-RAMOSUM, Journal of antibiotics, 51(11), 1998, pp. 983-990
Citations number
28
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology,"Biothechnology & Applied Migrobiology",Immunology
Journal title
ISSN journal
00218820
Volume
51
Issue
11
Year of publication
1998
Pages
983 - 990
Database
ISI
SICI code
0021-8820(1998)51:11<983:EEAAKR>2.0.ZU;2-S
Abstract
A kappa opioid receptor binding inhibitor was isolated from the fermen tation broth of a basidiomycete, Hericium ramosum CL24240 and identifi ed as erinacine E (1). Three analogs of 1 were produced by fermentatio n in other media and by microbial biotransformation. Of these compound s, 1 was shown to be the most potent binding inhibitor. Preliminary SA R studies of these compounds indicated that all functional groups and side chains were required for the activity. Compound 1 was a highly-se lective binding inhibitor for the kappa opioid receptor: 0.8 mu M (IC5 0) for kappa, > 200 mu M for mu, and > 200 mu M for delta opioid recep tor. Compound 1 suppressed electrically-stimulated twitch responses of rabbit vas deferens with an ED50 of 14 mu M. The suppression was reco vered adding a selective kappa opioid receptor antagonist nor-binaltor phimine, indicating that 1 is a kappa opioid receptor agonist.